WCN25-679 PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL

Conclusions: 1.The prevalence of CVC in the present study was 37.8%.MVC was present in 26.7%, AVC was seen in 21.5%, and 10.36% of subjects displayed both.2. Age$65 years, female sex, hypoalbuminaemia and increased Calcium Phosphorus product were significantly associated with CVC.HD vintage, comorbidities, Serum Ca, Pi, PTH, SAP and Vitamin D level were not significantly associated with CVC.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Authors

Institutions

Publication Details

Journal
Kidney International Reports
Published
2025-01-27
DOI
https://doi.org/10.1016/j.ekir.2024.11.230
Primary Topic
Erythropoietin and Anemia Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

WCN25-679 PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL

Hongyu Qiu, Xueqing Yu, Aimin Zhong, Wanhong Lu et al.
Kidney International Reports
Erythropoietin and Anemia Treatment
article

WCN25-679 PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL

Hongyu Qiu, Xueqing Yu, Aimin Zhong, Wanhong Lu, Xiaomei Peng, Qinkai Chen, Shuifu Tang, Zhizhen Hu, Ping Li, Aicheng Yang, Jianteng Xie
article en

Abstract

Conclusions: 1.The prevalence of CVC in the present study was 37.8%.MVC was present in 26.7%, AVC was seen in 21.5%, and 10.36% of subjects displayed both.2. Age$65 years, female sex, hypoalbuminaemia and increased Calcium Phosphorus product were significantly associated with CVC.HD vintage, comorbidities, Serum Ca, Pi, PTH, SAP and Vitamin D level were not significantly associated with CVC.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Kidney International ReportsVol. 10(2)
Nanchang University (CN), Sichuan University (CN), West China Hospital of Sichuan University (CN), First Affiliated Hospital of Guangzhou University of Chinese Medicine (CN), Jiangxi Provincial People's Hospital (CN), Hansoh Pharma (China) (CN), The People's Hospital of Guangxi Zhuang Autonomous Region (CN), Jiangmen Wuyi Traditional Chinese Medicine Hospital (CN), First Affiliated Hospital of Xi'an Jiaotong University (CN), Guangdong Provincial People's Hospital (CN), First Affiliated Hospital of Nanchang University (CN)
Good health and well-being
Openalex Percentile: Top 98%
Erythropoietin and Anemia Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

WCN25-679 PEGMOLESATIDE FOR THE TREATMENT OF ANEMIA IN NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: POST-HOC ANALYSIS OF A PHASE 3 TRIAL — Hongyu Qiu, Xueqing Yu, et al. · Kidney International Reports (2025) | TGRS Research Map | TGRS